v3.25.4
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Mar. 17, 2025
Jun. 20, 2023
Dec. 31, 2025
Dec. 31, 2024
Stockholders’ Equity (Details) [Line Items]        
Shares forfeited (in Shares)     8,127 0
Share-based compensation expense     $ 3.4 $ 3.1
Unamortized share-based compensation expense     $ 3.7  
Weighted average term     1 year 4 months 24 days  
Weighted average sales price per share     $ 16.01 $ 15.9
Maximum Gross Proceeds Percentage 2.00% 3.00%    
Offering cost $ 100.0 $ 75.0    
At-the-Market Offering Program [Member]        
Stockholders’ Equity (Details) [Line Items]        
Net proceeds from direct offering     $ 0.9 $ 38.4
Sold an aggregate shares (in Shares)     64,557 2,489,290
2021 Equity Incentive Plan [Member]        
Stockholders’ Equity (Details) [Line Items]        
Stock issued during period, restricted stock award grants (in Shares)     187,157 187,335
Issued and outstanding shares percentage     8.50% 8.50%
2021 Equity Incentive Plan [Member] | Employees of Manager [Member]        
Stockholders’ Equity (Details) [Line Items]        
Stock issued during period, restricted stock award grants (in Shares)     171,944 163,280
2021 Equity Incentive Plan [Member] | Employees of Manager [Member] | Resticted Stock Award [Member]        
Stockholders’ Equity (Details) [Line Items]        
Vesting period     3 years 3 years
2021 Equity Incentive Plan [Member] | Independent Member of Board [Member]        
Stockholders’ Equity (Details) [Line Items]        
Stock issued during period, restricted stock award grants (in Shares)     15,213 24,055
2021 Equity Incentive Plan [Member] | Independent Member of Board [Member] | Resticted Stock Award [Member]        
Stockholders’ Equity (Details) [Line Items]        
Vesting period     1 year 1 year
Common Stock [Member]        
Stockholders’ Equity (Details) [Line Items]        
Closing market price     $ 12.26 $ 15.42